Gregory C. Hadlock, Ph.D.
Affiliations: | 2010 | Pharmacology and Toxicology | University of Utah, Salt Lake City, UT |
Area:
Pharmacology, Toxicology, Neuroscience BiologyGoogle:
"Gregory Hadlock"Mean distance: 23748
Parents
Sign in to add mentor| Annette E. Fleckenstein | grad student | 2010 | University of Utah | |
| (Methamphetamine-induced dopamine transporter complex formation and neurotoxicity.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Charntikov S, Swalve N, Pittenger S, et al. (2016) Corrigendum to “Iptakalim attenuates self-administration and acquired goal-tracking behavior controlled by nicotine” [Neuropharmacology 75 (2013) 138–144] Neuropharmacology. 101: 590 |
| Charntikov S, Swalve N, Pittenger S, et al. (2013) Iptakalim attenuates self-administration and acquired goal-tracking behavior controlled by nicotine. Neuropharmacology. 75: 138-44 |
| McFadden LM, Hadlock GC, Allen SC, et al. (2012) Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure. The Journal of Pharmacology and Experimental Therapeutics. 340: 295-303 |
| Hadlock GC, Webb KM, McFadden LM, et al. (2011) 4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse. The Journal of Pharmacology and Experimental Therapeutics. 339: 530-6 |
| Hadlock GC, Nelson CC, Baucum AJ, et al. (2011) Ex vivo identification of protein-protein interactions involving the dopamine transporter. Journal of Neuroscience Methods. 196: 303-7 |
| Chu PW, Hadlock GC, Vieira-Brock P, et al. (2010) Methamphetamine alters vesicular monoamine transporter-2 function and potassium-stimulated dopamine release. Journal of Neurochemistry. 115: 325-32 |
| Hadlock GC, Chu PW, Walters ET, et al. (2010) Methamphetamine-induced dopamine transporter complex formation and dopaminergic deficits: the role of D2 receptor activation. The Journal of Pharmacology and Experimental Therapeutics. 335: 207-12 |
| Hadlock GC, Baucum AJ, King JL, et al. (2009) Mechanisms underlying methamphetamine-induced dopamine transporter complex formation. The Journal of Pharmacology and Experimental Therapeutics. 329: 169-74 |